Научная статья на тему 'TUBERCULOSIS IN WOMEN OF REPRODUCTIVE AGE'

TUBERCULOSIS IN WOMEN OF REPRODUCTIVE AGE Текст научной статьи по специальности «Фундаментальная медицина»

CC BY
48
13
i Надоели баннеры? Вы всегда можете отключить рекламу.
Ключевые слова
TUBERCULOSIS / WOMEN’S HEALTH / PREGNANCY

Аннотация научной статьи по фундаментальной медицине, автор научной работы — Goponiako Svetlana V.

The literature review presents data on the problem of respiratory tuberculosis in women of reproductive age. The review focuses on the epidemiology of tuberculosis in young women, their medical and social characteristics, factors predisposing to the disease, clinical peculiarities and drug resistance of the pathogen

i Надоели баннеры? Вы всегда можете отключить рекламу.
iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.
i Надоели баннеры? Вы всегда можете отключить рекламу.

Текст научной работы на тему «TUBERCULOSIS IN WOMEN OF REPRODUCTIVE AGE»

Проблемы здоровья и экологии/Health and Ecology Issues 2022;19(1):5-12

УДК 616.24-002.5-053.81-055.2 , .

https://doi.org/10.51523/2708-6011.2022-19-l-01

Tuberculosis in women of reproductive age

Svetlana V. Goponiako

Gomel State Medical University, Gomel, Belarus

Abstract

The literature review presents data on the problem of respiratory tuberculosis in women of reproductive age. The review focuses on the epidemiology of tuberculosis in young women, their medical and social characteristics, factors predisposing to the disease, clinical peculiarities and drug resistance of the pathogen.

Keywords: tuberculosis, women's health, pregnancy.

Conflict of interest. The author declares no apparent or potential conflicts of interest related to the publication of this article.

Funding. The study was conducted without sponsorship.

For citation: Goponiako SV. Tuberculosis in women of reproductive age. Health and Ecology Issues. 2022;19(1):5-12. DOI: https://doi.org/10.51523/2708-6011.2022-19-1-01

Туберкулез у женщин репродуктивного возраста

С. В. Гопоняко

Гомельский государственный медицинский университет, г. Гомель, Беларусь

Резюме

В обзоре литературы представлены данные по проблеме туберкулеза органов дыхания у женщин репродуктивного возраста. Рассмотрены вопросы по эпидемиологии туберкулеза у молодых женщин, их медико-социальная характеристика, факторы, предрасполагающие к развитию заболевания, клинические особенности и лекарственная устойчивость возбудителя.

Ключевые слова: туберкулез, женское здоровье, беременность.

Конфликт интересов. Автор заявляет об отсутствии явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.

Источники финансирования. Исследование проведено без спонсорской поддержки. Для цитирования: Гопоняко СВ. Туберкулез у женщин репродуктивного возраста. Проблемы здоровья и экологии.. 2022;19(1):5-12. DOI: https://doi.org/10.51523/2708-6011.2022-19-1-01

Introduction

Tuberculosis (TB) morbidity has declined steadily over the last years in the Republic of Belarus. However, Belarus is still among the high-priority countries for TB in the European region and bears the highest burden of multi-drug resistant (MDR) TB [1]. The World Health Organization (WHO) admits that men globally are more likely to develop TB, but at the same time, TB in women produces a hidden social-economic burden not to be reflected with epidemiological indices [2, 3]. TB affects women at an age of their highest reproductive, social, and economic activity, which makes the most negative impact on families, states, and health care systems [2, 3]. TB is one of the five most frequent infectious death causes in young women and mothers [2, 3, 4, 5, 6, 7]. The problem is even more serious in high HIV

© Svetlana V. Goponiako, 2022

associated TB prevalence regions [3, 4, 5, 6, 7]. TB in women is also epidemiologically important due to close contacts with children, which promotes the transmission of the TB infection [2, 3, 8].

Thus, a comprehensive study of TB in young women is topical for the Republic of Belarus and Gomel region in particular, as it is the one with the highest TB and HIV/TB prevalence. The greatest attention is to be paid to the epidemiology of TB in young women, its social-economic significance, factors predisposing to TB and clinical characteristics of the disease in women.

Epidemiology of TB in women of reproductive age

There is no global complete open access epidemiological information on TB in women

Проблемы здоровья и экологии/Health and Ecology Issues

2022;19(1):5-12

of reproductive age. Available evidence reflects only the situation in some regions of the world and has not been updated for many years. Thus, the latest world data on women's TB morbidity and mortality given in a WHO survey cover those from 1990 to 2013. More than 3 million TB cases and more than 500 thousand TB deaths in women are registered annually [4]. 900 million women worldwide have latent TB infection, which may progress to active disease [7]. The rates of TB morbidity, mortality and global TB burden are unknown for women of reproductive age and particularly pregnant women [6].

The research studying the sex and age structure of TB cases in the regions neighboring the Republic of Belarus showed an age-related peak incidence rate in women 25-34 years of age [9, 10]. Some regional investigations showed increasing TB mortality in young women during the first decade of the XXI century, particularly among those with the HIV-positive status [9].

The proportion of women's TB in the Republic of Belarus is about 25 % of new cases [1]. Few publications focusing on the sex / age structure of TB in Belarus have showed that women get sick with TB most often at the age of 25-44. The men to women ratio among patients with newly diagnosed TB is 3:1, and women of reproductive age have drug resistant TB more often than elder ones [11].

Globally obstetrical conditions are most often to cause unfavorable pregnancy course and maternal mortality. Infectious diseases cause about 28 % of the situations and TB is among the most frequent ones [2, 3]. There are no open access epidemiological data on the TB morbidity and prevalence in pregnant women as well as on HIV-associated and drug resistant TB. Therefore, many publications admit the necessity of a comprehensive epidemiologi-cal evaluation of TB in this category of patients [6, 7, 9, 11, 12, 13].

Medical and social aspects of TB in young women

Social related characteristics of men and women refer to "gender" unlike biological sex determinants. Higher TB rates in men may partly reflect epidemiological differences in their contacts with TB transmitters, risk of getting infected and progressing to disease. Some researches point out that women at early reproductive age may have a higher risk of infection to disease progression and higher mortality than men [2, 12].

TB in young women relates to both medical and socio-economic category. The health of young women greatly determines the demographic perspectives of a state and general well-being of families which closely associates with the most maternal role to give birth and raise children, as well as women's social and economic activities [2, 12]. Another important point is that mothers may transmit TB to their children having the closest contact with them [2, 3, 8].

Only a few Russian publications give social characteristics of women with TB. Researches carried out in the neighboring regions are obviously the most important for the Republic of Belarus due to similar epidemiological and socio-economic characteristics. The health care systems are also analogous and have traditionally prevailing specialized anti-TB services. Studies performed in Belarus and Russia have showed TB to equally affect women living in urban and rural areas [9, 10, 11]. Higher TB prevalence and less effectively organized TB screening were found out among unemployed women [11]. The women with TB found by XR screening were shown to be often MTB positive [11], which refers to longer lasting respiratory symptoms. The situation leads to accumulation of TB infection and its transmission to children who are the most susceptible. The unfavorable social status related to unemployment and homelessness was found to increase the risk of active TB development [9, 10, 11].

In the Republic of Belarus, the only research studying the social aspect of TB in women of reproductive age has been carried out in the Grodno region. Its findings presented in 2020 showed that 60 % of women firstly diagnosed with TB are unemployed despite their working age. Alcohol addicts were shown to make a higher proportion among women with drug-resistant TB than those with drug-sensitive TB (42.1 % compared to 25.7 %). Permanent disablement occurred in 13.1 % of female patients with drug-resistant TB and in 25.8 % of those with drug-sensitive TB [11]. These data must be obligatory considered when developing anti-TB measures for women in the Republic of Belarus.

Factors contributing to TB development in women of reproductive age

The risk factors of active TB development have been studied for many decades and are quite well-known. These are HIV-infection, immunosuppression, and cachexia of any genesis,

Проблемы здоровья и экологии/Health and Ecology Issues

2022;19(1):5-12

diabetes mellitus and others [3, 4]. The WHO underlines the importance of social factors for the TB development while admitting women to have a lower social risk than men [3]. Generally, women, if covered by available medical care, have better a health status as they pay more attention to it. This might be explained by pregnancy planning, taking more responsibility to medical recommendations and routing medical screenings [14, 15]. Thus, greater susceptibility to TB among women of reproductive age might have biological determinants. Therefore, to reveal and study the determinants is a priority task [3, 15, 16, 17, 20, 21].

The genetic determinants of susceptibility to TB have been recently reported to exist including those associated with the X-chro-mosome, which concerns gender differences in the development of the anti-tuberculous immune response. However, the lacking data about gene polymorphism cannot be used in clinical practice yet [20].

Immunity / hormonal interactions, as well as the influence of the sex hormones on the defense mechanisms and anti-TB response are being currently studied [17, 19, 20, 22, 23, 24]. Obviously, an understanding of TB activation triggers and infection to disease development in women must be related to this. The clue is likely to be found in these studies. The role of the sex hormones is also strongly confirmed by the fact of absent sex differences in TB susceptibility in boys and girls before puberty [20].

The male and female hormones have a different influence on the functions of T-lym-phocytes, neutrophils, macrophages, dendrite cells. Almost all components of the immune response are stimulated by the male and female sex hormones. Thus, it can be significant for anti-TB protection [20, 25, 26]. Adequate Th1 immune response is vital to resist mycobacte-rium tuberculosis (MTB). Estrogens are considered to promote a Th1-response. However, scientific studies show that the immuno-hormonal influence on the balance of a Th1/Th2 immune response is quite complicated. Thus, low levels of 17-estradiole potentiate a Th1-re-sponse leading to increased levels of tumor necrosis factor alpha (TNF-a). The high level, correspondingly, shifts the balance to Th2-re-action with a decrease in the cytokine level. The sex hormones also stimulate the functions of T-regulator lymphocytes. On the one hand, it might prevent effective MTB elimination. On the other hand, it might limit tissue alteration [25].

Estrogens promote the production of TNF-a and y-interferon and involve vitamin D into immune response [25, 27]. However, its role in anti-TB immunity remains undefined [25].

Macrophages are the main effector cells of anti-tuberculous immunity. The potentiating effect of estrogens on macrophages is considered certain. However, the real effect of the sex hormones on Th1/Th2 balance is much more complicated. Cell necrosis is known to contribute to MTB multiplication, whereas apoptosis — the regulated process — limits bacteria reproduction and stimulates defence. The necrosis / apoptosis balance is regulated by the humoral immune factors, which are in turn influenced by estrogens and progesterone [19, 23, 25].

Progesterone is a potent regulator of immune responses. It is also known as a natural suppressor and modulator of T-dependent immune reactions. Its influence on the functionality of T-lymphocytes, phagocytic activity of neutrophils and macrophages has also been described [19, 20, 23, 25, 28, 29]. Immune response effectors are directed by progesterone Th2-way stimulation and suppression of NK-cells. Progesterone is a key molecule involved in the regulation of Th1/Th2-cells, which is necessary for successful pregnancy. Progesterone has the leading role in the modulation of T-reg-cells. It advances the reversible suppression of cytotoxic cells proliferation and decreases the levels of TNF-a and y-interferon, which are the most important Th1 cytokines [25, 27, 28, 29].

Spontaneous apoptosis of neutrophils is stronger limited by both estrogens and progesterone in women compared to men. Neu-trophils cause a paraspecific tissue reaction and increase alteration through T-suppressors inhibiting lymphocytes [30]. The role of neu-trophils in the maintenance of effective anti-TB defense remains unclear [20, 25, 31].

In different periods of life, woman's organism endures global hormonal modifications such as during pregnancy and labor, within the postpartum period, after abortion (spontaneous or medical), on taking oral contraceptives. The conformations affect the immune status. The mechanisms of these immuno-hormonal interactions and their predicting effects require thorough studies to be used in the diagnostic algorithm for TB in women [25, 32, 33].

The investigation of the hormonal profile in women with pulmonary TB has showed an abnormal interrelation between the pituitary gonadotropes, suprarenal and sex gland hormones. It has found impaired ratios of follicle-stimulating hormone and luteinizing hormone, increased levels of cortisol, estradiole,

Проблемы здоровья и экологии/Health and Ecology Issues

2022;19(1):5-12

progesterone and prolactine, decreased levels of testosterone [32]. These abnormalities may determine TB development as well as be determined by TB. The detection of these disorders is important both for the diagnosis and prevention of TB in women [18, 19, 20, 22, 32].

The sex hormones influence the extension of TB lesions, MTB concentrations in affected tissues, severity and progression of TB inflammation at early and advanced stages [20, 22]. Thus, the experimental study has showed that the female sex hormones accelerate the severity of inflammation in lung tissues, cause early formation of granulomas and significantly elevate the levels of such humoral immune factors as TNF-a, y-interferon, interleukin-12 in blood serum [22]. Testosterone was found to be the hormone which enhances TB susceptibility [22].

The particular interest makes the question whether immune-hormonal interactions alter results of blood tests to detect anti-TB immune response — y-interferon release assays. Laboratory tests are preferable for pregnant women [35, 36, 37]. However, the informative value and specificity of y-interferon release assays in pregnant women have not been yet completely studied.

All the mechanisms might be important during pregnancy while the problem needs a special discussion.

Clinical manifestations of TB in women of reproductive age

The study of TB lung manifestations in young women is necessary to substantiate the algorithms of early diagnosis of the disease in target groups of patients.

Microbiological confirmation is a necessary standard of TB diagnosis nowadays [37, 38]. Quite often young women do not produce high concentrations of MTB in the sputum, therefore it appears impossible to find the pathogen in their samples especially by acid fast microscopy, which is a test with lacking sensitivity for early TB stages [10, 39, 40]. Firstly, that impedes the diagnosis, secondly, microscopy does not identify acid fast species and does not differentiate drug sensitive or resistant MTB which is critical in a high prevalence rate of MDR-TB. Moreover, undetectable concentrations of MTB in the sputum do not exclude MTB transmission especially to the most susceptible percipients. Children have the greatest risk of MTB transmission in a case of mother's TB disease due to the closest and prolonged contact [8]. Summarizing the substantiations,

highly sensitive molecular genetic methods are the most valuable for TB diagnosis in young women, as PCR tests are also much faster than culture cultivation [34, 35, 36]. Immunological lab tests for MTB detection, which are as highly sensitive as specific, must also be used for sputum negative TB suspects in complex diagnostics. A thorough analysis of MTB positive cases and those with undetectable concentrations of MTB in the sputum among women of reproductive age means to develop the optimal diagnostic approach using the whole arsenal of microbiological, genetic molecular, immuno-logical and radiological options.

As for the clinical variability of lung TB, focal and infiltrative forms prevail in young women [10, 11, 15, 32]. Disseminated forms occur most rarely. However, young women, including those with a HIV-negative status with no evident risks, may also develop extended pulmonary lesions. Actually, such cases are difficult to recognize due to unawareness and absence of concern for potentially severe and disseminated TB disease in women of reproductive age. Moreover, the disease might be not associated with high concentrations of MTB in the sputum for a long time, which impedes the pathogen detection. The clue to proper diagnosis should be a clear understanding of diverse TB symptoms and thorough investigation of the disease history, the duration and severity of intoxication and respiratory symptoms. Highly sensitive PCR and immunological tests are to be used. Microbiological and molecular genetic testing of biopsy material for MTB, together with histology, is obligatory and critically important [39].

The clinical peculiarities of TB in women with different risk factors are to be further investigated. HIV-associated TB often has a manifest presentation and pneumonia-like course. The destruction of lung tissue and high concentrations of MTB in the sputum are often found in both immune compromised patients and alcohol abusers [10, 11, 15]. Thus, differentiated algorithms for the contingents are needed. The diagnostic approach should focus on the clinical nuances of TB in young women and form wariness in medical practitioners and specialists.

Primary and secondary MTB drug-resistance in women requires a particular attention. An understanding of their significance as a source of TB infection is necessary for an objective estimation of the women's role in the transmission of multi-resistant MTB among population. The estimation of MDR-TB prevalence among young women is important for the

Проблемы здоровья и экологии/Health and Ecology Issues

optimization of TB diagnosis in women as well in pregnancy. Invasive diagnostics, such as fi-brobronchoscopy, video-assisted thoracoscopy with lung biopsy are limitedly used during pregnancy. It is very important to be aware about possible primary MTB drug resistance in young women to clearly substantiate the endo-scopic manipulations for obtaining bronchial aspirate or biopsy material for MTB detection and drug susceptibility testing. Today there is no available comprehensive information about MDR-TB morbidity and prevalence among young women.

2022;19(1):5-12

Conclusion

It is very important to develop a comprehensive substantiated approach to TB diagnosis in women of reproductive age including pregnant ones. It must be based on thorough consideration of early manifestations, purposeful search of symptoms and application of MTB detecting tests for patients with respiratory or intoxication complaints during pregnancy. It is necessary for saving mothers" health and prevention of MTB transmission to newborns and to other pregnant and postpartum women in inpatient and outpatient medical centres.

References

1. Tuberculosis profile: Belarus [Electronic resource]. World Health Organization. [date of access 2021 December 10]. Available from: https://worldhealthorg.shin-yapps.io/tb_profiles/?_inputs_&entity_type=%22coun-try%22&lan=%22RU%22&iso2=%22BY%22

2. Technical Brief. Tuberculosis, Gender and Human Rights [Electronic resource]. February 2020, Geneva, Switzerland. TheGlobalFund. [date of access 2021 December 10]. Available from: https://www.theglobalfund.org/me-dia/6349/core_tbhumanrightsgenderequality_technical-brief_en.pdf

3. Tuberculosis in women. [Electronic resource]. World Health Organization [date of access 2021 December 10]. Available from: http://www.who.int/tb/publications/ tb_women_factsheet.pdf

4. WHO, UNICEF, UNFPA Trends in Maternal Mortality: 1990 to 2013. Estimates by WHO, UNICEF, UNFPA, the World Bank and the United Nations Population Division. [Electronic resource] Publication date: 12 Sep 2014. United Nations Population Fund [date of access 2021 December 10]. Available from: https://www.unfpa.org/publica-tions/trends-maternal-mortality-1990-2013

5. Say L, Chou D, Gemmill A, Tungalp O, Moller AB, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun;2(6):e323-333. DOI: https://doi.org/10.1016/S2214-109X(14)70227-X

6. Sugarman J, Colvin C, Moran AC, Oxlade O. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health. 2014 Dec;2(12):e710-716. DOI: https://doi.org/10.1016/S2214-109X(14)70330-4

7. Bates M, Ahmed Y, Kapata N, Maeurer M, Mwaba P, Zumla A. Perspectives on tuberculosis in pregnancy. Int J Infect Dis. 2015 Mar;32:124-127.

DOI: https://doi.org/10.1016/j.ijid.2014.12.014

8. Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis. 2012 May 15;205 Suppl 2:S216-227.

DOI: https://doi.org/10.1093/infdis/jis009

9. Galkin VB, Mushkin AYu, Muraviev AN, Serdobint-sev MS, Belilovsky EM, Sinitsyn MV The gender and age structure of the incidence of tuberculosis (various localizations) in the Russian Federation: changes over the XXIth century. Tuberculosis and Lung Diseases. 2018;96(11):17-26. (In Russ.).

DOI: https://doi.org/10.21292/2075-1230-2018-96-11-17-26

10. Igembaeva KS, Igembaeva RS, Tokpayeva AZh, Selikhanova NK, Salamatov A. Tuberculosis in women of reproductive age. Science and Healthcare. 2014;(3):74-75.

[cited 2021 Dec 10]. Available from: https://cyberleninka. ru/article/n/tuberkulez-legkih-u-zhenschin-reproduktiv-nogo-vozrasta (In Russ.)

11. Demidik SN, Wolf SB, Alekso EN. Medical and social aspects and results of treatment of tuberculosis of the female population of the Grodno region. Journal of Grodno State Medical University. 2020;18(1):11-16. [cited 2021 Dec 10]. Available from: http://elib.grsmu.by/handle/ files/16726 (In Russ.).

12. Mordyk AV, Puzyreva LV, Kravchenko EN, Valeeva GA. The influence of pregnancy on the course of a specific process in the lungs. Siberian Medical Review. 2015;(4)94. [cited 2021 Dec 10]. Available from: https://cyberleninka. ru/article/n/vliyanie-beremennosti-na-techenie-spetsi-ficheskogo-protsessa-v-legkih (In Russ.).

13. Bothamley GH, Ehlers C, Salonka I., Skrahina A, Orcau A, Codecasa LR, [et al.]. Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey. BMC Pregnancy Childbirth. 2016;(16)304. [cited 2021 Dec 10]. Available from: https://doi.org/10.1186/s12884-016-1096-4

14. Kiselevskaya-Babinina VYa, Sannikova TE, Romanyukha AA, Karkach AS. Modeling of gender differences in tuberculosis prevalence. Math. Biol. Bioinf. 2018;13(2):308-321. [cited 2021 Dec 10]. Available from: https://doi.org/10.17537/2018.13.308 (In Russ.).

15. Koretskaya NM, Narkevich AA, Narkevich AN. Gender features of newly diagnosed infiltrative pulmonary tuberculosis. Pulmonologiya. 2014;(1):77-80. (In Russ.). DOI: https://doi.org/10.18093/0869-0189-2014-0-1-77-80

16. Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med. 2009 Dec;6(12):e1000199. DOI: https://doi.org/10.1371/journal.pmed.1000199

17. McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz). 2011 Jun;59(3):203-213.

DOI: https://doi.org/10.1007/ s00005-011-0124-3

18. Guerrini V. Sex hormones and innate immunity in tuberculosis. National Institutes of Health. Newark, NJ. U.S. [cited 2021 Dec 10]. Available from: https://grant-ome.com/grant/NIH/R21-AI153660-01

19. Zhao Y, Ying H, Demei J, Xie J. Tuberculosis and sexual inequality: the role of sex hormones in immunity. Crit Rev Eukaryot Gene Expr. 2012;22(3):233-241.

DOI: https://doi.org/10.1615/critreveukargeneexpr.v22. i3.60

20. Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014 Jul 15;209 Suppl 3:S100-6.

DOI: https://doi.org/10.1093/infdis/jiu147

21. Chu Y, Soodeen-Lalloo AK, Huang J, Yang G, Chen F, Yin H, Sha W, Huang X, Shi J, Feng Y. Sex Disparity in Severity of Lung Lesions in Newly Identified Tu-

2022;19(1):5-12 Проблемы здоровья и экологии/Health and Ecology Issues

berculosis Is Age-Associated. Front Med (Lausanne). 2019 Jul 17;6:163.

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

DOI: https://doi.org/10.3389/fmed.2019.00163

22. Bini EI, Mata Espinosa D, Marquina Castillo B, Barrios Payan J, Colucci D, Cruz AF, [et al.] The influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosis. PLoS One. 2014 Apr 10;9(4):e93831.

DOI: https://doi.org/10.1371/journal.pone.0093831

23. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008 Sep;8(9):737-744.

DOI: https://doi.org/10.1038/nri2394

24. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475-527. DOI: https:// doi.org/10.1146/annurev-immunol-032712-095939

25. Gerlinskaya LA, Varlachev AV, Krotov GI, Kont-sevaya GV, Moshkin MP. Mother-fetus immunogenet-ic dialogue as a factor of progeny immune system development. Vavilov Journal of Genetics and Breeding. 2018;22(8):1009-1019. (In Russ.).

DOI: https://doi.org/10.18699/VJ18.444

26. Hall OJ, Klein SL. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol. 2017 Sep;10(5):1097-1107.

DOI: https://doi.org/10.1038/mi.2017.35

27. Nashold FE, Spach KM, Spanier JA, Hayes CE. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol. 2009 Sep 15;183(6):3672-81.

DOI: https://doi.org/10.4049/jimmunol.0901351

28. Shah NM, Lai PF, Imami N, Johnson MR. Progesterone-Related Immune Modulation of Pregnancy and Labor. Front Endocrinol (Lausanne). 2019 Mar 29;10:198. DOI: https://doi.org/10.3389/fendo.2019.00198

29. AbdulHussain G, Azizieh F, Makhseed M, Ragh-upathy R. Effects of Progesterone, Dydrogesterone and Estrogen on the Production of Th1/Th2/Th17 Cytokines by Lymphocytes from Women with Recurrent Spontaneous Miscarriage. J Reprod Immunol. 2020 Aug;140:103132. DOI: https://doi.org/10.1016/jjri.2020.103132

30. Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Perei-ra M, Fitzpatrick JM, Webb DW, Watson RW. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood. 2003 Oct 1;102(7):2653-2659.

DOI: https://doi.org/10.1182/blood-2003-02-0649

31. Yang CT, Cambier CJ, Davis JM, Hall CJ, Crosier PS, Ramakrishnan L. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of my-

cobacteria phagocytosed from infected macrophages. Cell

Host Microbe. 2012 Sep 13;12(3):301-12.

DOI: https://doi.org/10.1016/j.chom.2012.07.009

32. Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019 Jan 8;13(1):2.

DOI: https://doi.org/10.1186/s40246-018-0185-z

33. Loto OM, Awowole I. Tuberculosis in pregnancy: a review. J Pregnancy. 2012;2012:379271.

DOI: https://doi.org/10.1155/2012/379271

34. Cain MA, Whiteman VE, Buhari MA, Louis JM. Positive interferon-y release assay leading to a diagnosis of Mycobacterium tuberculosis pericarditis in pregnancy. Obstet Gynecol. 2014 Aug;124(2 Pt 2 Suppl 1):475-477. DOI: https://doi.org/10.1097/AOG.0000000000000272

35. Lighter-Fisher J, Surette AM. Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy. Obstet Gynecol. 2012 Jun;119(6):1088-1095.

DOI: https://doi.org/10.1097/AOG.0b013e3182546aff

36. LaCourse SM, Cranmer LM, Matemo D, Kinuth-ia J, Richardson BA, Horne DJ, John-Stewart G. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting. J Acquir Immune Defic Syndr. 2017 May 1;75(1):128-136.

DOI: https://doi.org/10.1097/QAI.0000000000001298

37. Resolution of the Ministry of Health of the Republic of Belarus No.26 dated 04.04.2019 "About the approval of the clinical protocol on the diagnosis and treatment of patients with tuberculosis (adult and children population)". [Electronic resource]. Pravo.by. [date of access 2021 December 18]. Available from: https://www.bsmu.by/ downloads/vrachu/belnom/klin_tuberkulez.pdf

(In Russ.).

38. World Health Organization. Global Tuberculosis Report 2021. [cited 2021 Dec 10]. Available from: https://reliefweb.int/sites/reliefweb.int/files/re-sources/9789240037021-eng.pdf

39. Каторгин НА, Стаханов ВА, Гедымин ЛЕ. Диссеминированный туберкулез легких у молодой женщины: ошибки диагностики. Лечебное дело. 2012; (1):85-94. [дата обращения 2021 декабрь 10]. Режим доступа: https://cyberleninka.ru/article/n/disseminiro-vannyy-tuberkulez-legkih-u-molodoy-zhenschiny-oshib-ki-diagnostiki

40. Nabulsi BK, Kadi M, AlAbadi H, Alnabulsi RK, Badeghiesh A, et al. Pregnant Woman with Fulminant Disseminated TB to the Omentum and Placenta. Gynecol Obstet (Sunnyvale). 2014;4:225.

DOI: https://doi.org/10.4172/2161-0932.1000225

Список литературы

1. Tuberculosis profile: Belarus [Electronic resource]. World Health Organization. [date of access 2021 December 10]. Available from: https://worldhealthorg.shinyapps.io/ tb_profiles/?_inputs_&entity_type=%22country%22&lan= %22RU%22&iso2=%22BY%22

2. Technical Brief. Tuberculosis, Gender and Human Rights [Electronic resource]. February 2020, Geneva, Switzerland. TheGlobalFund. [date of access 2021 December 10]. Available from: https://www.theglobalfund. org/media/6349/core_tbhumanrightsgenderequality_ technicalbrief_en.pdf

3. Tuberculosis in women. [Electronic resource]. World Health Organization [date of access 2021 December 10]. Available from: http://www.who.int/tb/publications/ tb_women_factsheet.pdf

4. WHO, UNICEF, UNFPA Trends in Maternal Mortality: 1990 to 2013. Estimates by WHO, UNICEF,

UNFPA, the World Bank and the United Nations Population Division. [Electronic resource] Publication date: 12 Sep 2014. United Nations Population Fund [date of access 2021 December 10]. Available from: https://www.unfpa. org/publications/trends-maternal-mortality-1990-2013

5. Say L, Chou D, Gemmill A, Tungalp O, Moller AB, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun;2(6):e323-333. DOI: https://doi.org/10.1016/S2214-109X(14)70227-X

6. Sugarman J, Colvin C, Moran AC, Oxlade O. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health. 2014 Dec;2(12):e710-716. DOI: https://doi.org/10.1016/S2214-109X(14)70330-4

7. Bates M, Ahmed Y, Kapata N, Maeurer M, Mwaba P, Zumla A. Perspectives on tuberculosis in pregnancy. Int J Infect Dis. 2015 Mar;32:124-127.

DOI: https://doi.org/10.1016/j.ijid.2014.12.014

Проблемы здоровья и экологии/Health and Ecology Issues 2022;19(1):5-12

8. Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis. 2012 May 15;205 Suppl 2:S216-27.

DOI: https://doi.org/10.1093/infdis/jis009

9. Галкин ВБ, Мушкин АЮ, Муравьев АН, Сердо-бинцев МС, Белиловский ЕМ, Синицын МВ. Половозрастная структура заболеваемости туберкулезом различных локализаций в Российской Федерации: динамика в XXI в. Туберкулез и болезни легких. 2018;96(11):17-26. DOI: https://doi.org/10.21292/2075-1230-2018-96-11-17-26

10. Игембаева КС, Игембаева РС, Токпаева АЖ, Селиханова НК, Саламатов А. Туберкулез легких у женщин репродуктивного возраста. Наука и здравоохранение. 2014;(3):74-75. [дата обращения 2021 декабрь 10]. Режим доступа: https://cyberleninka.ru/article/n/ tuberkulez-legkih-u-zhenschin-reproduktivnogo-vozrasta

11. Демидик СН, Вольф СБ, Алексо ЕН. Медико-социальные аспекты и результаты лечения туберкулеза женского населения Гродненской области. Журнал Гродненского государственного медицинского университета. 2020;18(1):11-16. [дата обращения 2021 декабрь 10]. Режим доступа: http://elib.grsmu.by/handle/ files/16726

12. Мордык АВ, Пузырева ЛВ, Кравченко ЕН, Ва-леева ГА. Влияние беременности на течение специфического процесса в легких. Сибирское медицинское обозрение. 2015;(4)94. [дата обращения 2021 декабрь 10]. Режим доступа: https://cyberleninka.ru/article/n/ vliyanie-beremennosti-na-techenie-spetsificheskogo-protsessa-v-legkih

13. Bothamley GH, Ehlers C, Salonka I., Skrahina A, Orcau A, Codecasa LR, et al. Confalonieri M. Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey. BMC Pregnancy Childbirth. 2016;(16)304.

DOI: https://doi.org/10.1186/s12884-016-1096-4

14. Киселевская-Бабинина ВЯ, Санникова ТЕ, Ро-манюха АА, Каркач АС. Моделирование влияний тендерных различий на заболеваемость туберкулёзом. Ма-тем биология и биоинформ. 2018;13(2):308-321.

DOI: https://doi.org/10.17537/2018.13.308

15. Корецкая НМ, Наркевич АА, Наркевич АН. Гендерные особенности впервые выявленного ин-фильтративного туберкулеза легких. Пульмонология. 2014;(1):77-80.

DOI: https://doi.org/10.18093/0869-0189-2014-0-1-77-80

16. Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med. 2009 Dec;6(12):e1000199. DOI: https://doi.org/10.1371/journal.pmed.1000199

17. McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz). 2011 Jun;59(3):203-213. DOI: https://doi.org/10.1007/s00005-011-0124-3

18. Guerrini V. Sex hormones and innate immunity in tuberculosis. National Institutes of Health. Newark, NJ. U.S. [дата обращения 2021 декабрь 10]. Режим доступа: https://grantome.com/grant/NIH/R21-AI153660-01

19. Zhao Y, Ying H, Demei J, Xie J. Tuberculosis and sexual inequality: the role of sex hormones in immunity. Crit Rev Eukaryot Gene Expr. 2012;22(3):233-41.

DOI: https://doi.org/10.1615/critreveukargeneexpr.v22. i3.60

20. Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014 Jul 15;209 Suppl 3:S100-6.

DOI: https://doi.org/10.1093/infdis/jiu147

21. Chu Y, Soodeen-Lalloo AK, Huang J, Yang G, Chen F, Yin H, Sha W, et al. Sex Disparity in Severity

of Lung Lesions in Newly Identified Tuberculosis Is Age-Associated. Front Med (Lausanne). 2019 Jul 17;6:163. DOI: https://doi.org/10.3389/fmed.2019.00163

22. Bini EI, Mata Espinosa D, Marquina Castillo B, Barrios Payan J, Colucci D, Cruz AF, et al. The influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosis. PLoS One. 2014 Apr 10;9(4):e93831.

DOI: https://doi.org/10.1371/journal.pone.0093831

23. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008 Sep;8(9):737-744.

DOI: https://doi.org/10.1038/nri2394

24. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475-527. DOI: https:// doi.org/10.1146/annurev-immunol-032712-095939

25. Герлинская ЛА, Варлачев АВ, Кротов ГИ, Концевая ГВ, Мошкин МП. Иммуногенетический диалог матери и эмбрионов как фактор становления иммунного статуса потомков. Вавиловский журнал генетики и селекции. 2018;22(8):1009-1019.

DOI: https://doi.org/10.18699/VJ18.444

26. Hall OJ, Klein SL. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol. 2017 Sep;10(5):1097-1107.

DOI: https://doi.org/10.1038/mi.2017.35

27. Nashold FE, Spach KM, Spanier JA, Hayes CE. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol. 2009 Sep 15;183(6):3672-81.

DOI: https://doi.org/10.4049/jimmunol.0901351

28. Shah NM, Lai PF, Imami N, Johnson MR. Progesterone-Related Immune Modulation of Pregnancy and Labor. Front Endocrinol (Lausanne). 2019 Mar 29;10:198.

DOI: https://doi.org/10.3389/fendo.2019.00198

29. AbdulHussain G, Azizieh F, Makhseed M, Raghupathy R. Effects of Progesterone, Dydrogesterone and Estrogen on the Production of Th1/Th2/Th17 Cytokines by Lymphocytes from Women with Recurrent Spontaneous Miscarriage. J Reprod Immunol. 2020 Aug;140:103132. DOI: https://doi.org/10.1016/jjri.2020.103132

30. Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, Watson RW. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood. 2003 Oct 1;102(7):2653-2659.

DOI: https://doi.org/10.1182/blood-2003-02-0649

31. Yang CT, Cambier CJ, Davis JM, Hall CJ, Crosier PS, Ramakrishnan L. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe. 2012 Sep 13;12(3):301-312.

DOI: https://doi.org/10.1016/j.chom.2012.07.009

32. Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019 Jan 8;13(1):2.

DOI: https://doi.org/10.1186/s40246-018-0185-z

33. Loto OM, Awowole I. Tuberculosis in pregnancy: a review. J Pregnancy. 2012;2012:379271.

DOI: https://doi.org/10.1155/2012/379271

34. Cain MA, Whiteman VE, Buhari MA, Louis JM. Positive interferon-y release assay leading to a diagnosis of Mycobacterium tuberculosis pericarditis in pregnancy. Obstet Gynecol. 2014 Aug;124(2 Pt 2 Suppl 1):475-477. DOI: https://doi.org/10.1097/AOG.0000000000000272

35. Lighter-Fisher J, Surette AM. Performance of an interferon-gamma release assay to diagnose latent

2022;19(1):5-12 Проблемы здоровья и экологии/Health and Ecology Issues

tuberculosis infection during pregnancy. Obstet Gynecol. 2012 Jun;119(6):1088-1095.

DOI: https://doi.org/10.1097/AOG.0b013e3182546aff

36. LaCourse SM, Cranmer LM, Matemo D, Kinuthia J, Richardson BA, Horne DJ, John-Stewart G. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting. J Acquir Immune Defic Syndr. 2017 May 1;75(1):128-136. DOI: https://doi.org/10.1097/QAI.0000000000001298

37. Постановление Министерства здравоохранения Республики Беларусь №26 от 04.04.2019 «Об утверждении клинического протокола «Диагностика и лечение пациентов с туберкулезом (взрослое, детское население». [Electronic resource]. Pravo.by. [date of access 2021 December 18]. Available from: https://www.bsmu.by/ downloads/vrachu/belnom/klin_tuberkulez.pdf

38. World Health Organization. Global Tuberculosis Report 2021. [date of access 2021 Dec 10]. Available from: https://reliefweb.int/sites/reliefweb.int/files/re-sources/9789240037021-eng.pdf

39. Каторгин НА, Стаханов ВА, Гедымин ЛЕ. Дис-семинированный туберкулез легких у молодой женщины: ошибки диагностики. Лечебное дело. 2012; (1):85-94. [дата обращения 2021 декабрь 10]. Режим доступа: https://cyberleninka.ru/article/n/disseminirovannyy-tuberkulez-legkih-u-molodoy-zhenschiny-oshibki-diagnostiki

40. Nabulsi BK, Kadi M, AlAbadi H, Alnabulsi RK, Badeghiesh A, et al. Pregnant Woman with Fulminant Disseminated TB to the Omentum and Placenta. Gynecol Obstet (Sunnyvale). 2014; 4:225.

DOI: https://doi.org/10.4172/2161-0932.1000225

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

Information about the author /Информация об авторе

Svetlana V. Goponiako, Senior Lecturer at the Phthisiopulmonology Department with the course of the Faculty of Professional Development and Retraining, Gomel State Medical University, Gomel, Belarus

ORCID: https://orcid.org/0000-0001-9965-7755 e-mail: indigomind@mail.ru

Гопоняко Светлана Владимировна, старший преподаватель кафедры фтизиопульмонологии с курсом ФПКиП, УО «Гомельский государственный медицинский университет», Гомель, Беларусь

ORCID: https://orcid.org/0000-0001-9965-7755 e-mail: indigomind@mail.ru

Corresponding author / Автор, ответственный за переписку

Svetlana V. Goponiako Гопоняко Светлана Владимировна

e-mail: indigomind@mail.ru e-mail: indigomind@mail.ru

Received / Поступила в редакцию 10.12.2021 Accepted / Поступила после рецензирования 03.01.2022 Revised / Принята к публикации 17.02.2022

i Надоели баннеры? Вы всегда можете отключить рекламу.